Validation of EmPHasis-10 health-related quality of life assessment tool in Canadian patients with pulmonary hypertension.
A. McBride (Calgary, Canada), D. Helmersen (Calgary, Canada), N. Hirani (Calgary, Canada), M. Thakrar (Calgary, Canada), M. Kularatne (Calgary, Canada), J. Liu (Calgary, Canada), L. Harper (Calgary, Canada), H. Iqbal (Calgary, Canada), A. Naser (Calgary, Canada), R. Varughese (Calgary, Canada), J. Weatherald (Calgary, Canada), J. Weatherald (Edmonton, Canada)
Source: International Congress 2022 – Risk assessment in pulmonary arterial hypertension
Session: Risk assessment in pulmonary arterial hypertension
Session type: Thematic Poster
Number: 460
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. McBride (Calgary, Canada), D. Helmersen (Calgary, Canada), N. Hirani (Calgary, Canada), M. Thakrar (Calgary, Canada), M. Kularatne (Calgary, Canada), J. Liu (Calgary, Canada), L. Harper (Calgary, Canada), H. Iqbal (Calgary, Canada), A. Naser (Calgary, Canada), R. Varughese (Calgary, Canada), J. Weatherald (Calgary, Canada), J. Weatherald (Edmonton, Canada). Validation of EmPHasis-10 health-related quality of life assessment tool in Canadian patients with pulmonary hypertension.. 460
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|